http://jcps.bjmu.edu.cn
Pharmacovigilance evaluation of enfortumab vedotin using the FDA Adverse Event Reporting System
Hui Yang, Haozhou Wang, Zhuoling An
Journal of Chinese Pharmaceutical Sciences . 2023, (2): 130 -137 .  DOI: 10.5246/jcps.2023.02.011

About Journal | Info for Authors | Statements | Peer Review Policy | Submission | Copyright Info
京ICP备05051953号-7
Copyright © Journal of Chinese Pharmaceutical Sciences, School of Pharmaceutical Sciences, Peking University
Tel./Fax: +86-10-82801713, E-mail: jcps@bjmu.edu.cn
Powered by Beijing Magtech Co., Ltd.